- Home
- BDRX vs RVYL Comparison
BDRX vs RVYL Comparison
Compare BDRX & RVYL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDRX
- RVYL
- Stock Information
- Founded
- BDRX 2000
- RVYL 2007
- Country
- BDRX United Kingdom
- RVYL United States
- Employees
- BDRX N/A
- RVYL N/A
- Industry
- BDRX Biotechnology: Pharmaceutical Preparations
- RVYL Professional Services
- Sector
- BDRX Health Care
- RVYL Consumer Discretionary
- Exchange
- BDRX Nasdaq
- RVYL Nasdaq
- Market Cap
- BDRX 5.8M
- RVYL 5.4M
- IPO Year
- BDRX N/A
- RVYL N/A
- Fundamental
- Price
- BDRX $0.88
- RVYL $0.75
- Analyst Decision
- BDRX
- RVYL Hold
- Analyst Count
- BDRX 0
- RVYL 1
- Target Price
- BDRX N/A
- RVYL N/A
- AVG Volume (30 Days)
- BDRX 3.1M
- RVYL 24.6M
- Earning Date
- BDRX 04-11-2025
- RVYL 08-12-2025
- Dividend Yield
- BDRX N/A
- RVYL N/A
- EPS Growth
- BDRX N/A
- RVYL N/A
- EPS
- BDRX N/A
- RVYL N/A
- Revenue
- BDRX N/A
- RVYL $54,357,000.00
- Revenue This Year
- BDRX N/A
- RVYL $27.50
- Revenue Next Year
- BDRX N/A
- RVYL $35.71
- P/E Ratio
- BDRX N/A
- RVYL N/A
- Revenue Growth
- BDRX N/A
- RVYL N/A
- 52 Week Low
- BDRX $0.78
- RVYL $0.36
- 52 Week High
- BDRX $41.50
- RVYL $2.40
- Technical
- Relative Strength Index (RSI)
- BDRX 37.66
- RVYL 48.90
- Support Level
- BDRX $0.83
- RVYL $0.76
- Resistance Level
- BDRX $0.97
- RVYL $0.91
- Average True Range (ATR)
- BDRX 0.11
- RVYL 0.09
- MACD
- BDRX 0.00
- RVYL 0.01
- Stochastic Oscillator
- BDRX 18.81
- RVYL 27.28
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.
About RVYL Ryvyl Inc.
Ryvyl Inc is a technology company that develops, markets and sells blockchain-based payment solutions, which offers improvements to the payment solutions marketplace. Its focus is developing and monetizing disruptive blockchain-based applications, integrated within an end-to-end suite of financial products, capable of supporting a multitude of industries. Its proprietary, blockchain-based systems are designed to facilitate, record, and store a limitless volume of tokenized assets, representing cash or data, on a secured immutable blockchain-based ledger. It has two reportable segments North America and International. It generates the majority of its revenue from North America.